ZA200807133B - Technology for preparation of macromolecular microspheres - Google Patents
Technology for preparation of macromolecular microspheresInfo
- Publication number
- ZA200807133B ZA200807133B ZA200807133A ZA200807133A ZA200807133B ZA 200807133 B ZA200807133 B ZA 200807133B ZA 200807133 A ZA200807133 A ZA 200807133A ZA 200807133 A ZA200807133 A ZA 200807133A ZA 200807133 B ZA200807133 B ZA 200807133B
- Authority
- ZA
- South Africa
- Prior art keywords
- preparation
- technology
- macromolecular microspheres
- microspheres
- macromolecular
- Prior art date
Links
- 239000004005 microsphere Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/57—Protease inhibitors from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
- A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01018—Exo-alpha-sialidase (3.2.1.18), i.e. trans-sialidase
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
- Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Pulmonology (AREA)
- Diabetes (AREA)
- Otolaryngology (AREA)
- Virology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Obesity (AREA)
- Communicable Diseases (AREA)
- Tropical Medicine & Parasitology (AREA)
- Oncology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Endocrinology (AREA)
- Nutrition Science (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US76200206P | 2006-01-24 | 2006-01-24 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200807133B true ZA200807133B (en) | 2009-05-27 |
Family
ID=38197716
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200807133A ZA200807133B (en) | 2006-01-24 | 2008-08-19 | Technology for preparation of macromolecular microspheres |
Country Status (13)
Country | Link |
---|---|
US (7) | US20070190163A1 (xx) |
EP (1) | EP1981483A1 (xx) |
JP (2) | JP5457680B2 (xx) |
KR (5) | KR101787939B1 (xx) |
CN (2) | CN104758253A (xx) |
AU (1) | AU2007233349A1 (xx) |
BR (1) | BRPI0706947B8 (xx) |
CA (2) | CA2639925C (xx) |
HK (1) | HK1210720A1 (xx) |
IL (2) | IL193001A (xx) |
RU (2) | RU2464973C2 (xx) |
WO (1) | WO2007114881A1 (xx) |
ZA (1) | ZA200807133B (xx) |
Families Citing this family (88)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003080149A2 (en) | 2002-03-20 | 2003-10-02 | Mannkind Corporation | Inhalation apparatus |
KR20050085130A (ko) * | 2002-11-22 | 2005-08-29 | 유 망 | 광범위 스펙트럼의 항-바이러스 치료제 및 예방제 |
US7807174B2 (en) * | 2002-11-22 | 2010-10-05 | Nexbio, Inc. | Class of therapeutic protein based molecules |
US8512710B2 (en) | 2002-11-22 | 2013-08-20 | Ansun Biopharma, Inc. | Class of therapeutic protein based molecules |
DE602005024413D1 (de) | 2004-08-20 | 2010-12-09 | Mannkind Corp | Katalyse der diketopiperazinsynthese |
ES2540886T3 (es) | 2004-08-23 | 2015-07-14 | Mannkind Corporation | Sales de dicetopiperazina para la administración de fármacos |
KR101557502B1 (ko) | 2005-09-14 | 2015-10-06 | 맨카인드 코포레이션 | 결정질 미립자 표면에 대한 활성제의 친화력의 증가를기반으로 하는 약물 제제의 방법 |
KR101787939B1 (ko) | 2006-01-24 | 2017-10-18 | 안선 바이오파르마, 아이엔씨. | 고분자 미소 구체들의 조제를 위한 기술 |
AU2007216966C1 (en) | 2006-02-22 | 2014-03-20 | Mannkind Corporation | A method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent |
AU2007297484B2 (en) * | 2006-09-18 | 2013-07-18 | Global Life Sciences Solutions Usa Llc | Preparation of glassified biological reagents |
WO2009015286A2 (en) * | 2007-07-24 | 2009-01-29 | Nexbio, Inc. | Technology for the preparation of microparticles |
EP2534957B1 (en) | 2007-12-14 | 2015-05-27 | AeroDesigns, Inc | Delivering aerosolizable products |
US9994585B2 (en) | 2007-12-31 | 2018-06-12 | Aphios Corporation | Transplantation therapies |
PL2293833T3 (pl) | 2008-06-13 | 2016-08-31 | Mannkind Corp | Inhalator proszkowy i układ do dostarczania leku |
US8485180B2 (en) | 2008-06-13 | 2013-07-16 | Mannkind Corporation | Dry powder drug delivery system |
EP2609954B1 (en) | 2008-06-20 | 2021-12-29 | MannKind Corporation | An interactive apparatus for real-time profiling of inhalation efforts |
CN102215871B (zh) * | 2008-09-12 | 2016-06-29 | 圣安德鲁斯大学董事会 | 糖结合分子 |
US8314106B2 (en) | 2008-12-29 | 2012-11-20 | Mannkind Corporation | Substituted diketopiperazine analogs for use as drug delivery agents |
EP2389173A1 (en) * | 2009-01-22 | 2011-11-30 | Sanofi | New combination of active ingredients containing a non steroidal anti inflammatory drug and a colchicoside derivative |
CA2780193A1 (en) * | 2009-11-06 | 2011-05-12 | Nexbio, Inc. | Methods, compounds and compositions for treatment and prophylaxis in the respiratory tract |
WO2011081937A1 (en) | 2009-12-15 | 2011-07-07 | Gilead Sciences, Inc. | Corticosteroid-beta-agonist-muscarinic antagonist compounds for use in therapy |
AU2010332958B2 (en) | 2009-12-15 | 2014-09-18 | Ascendis Pharma Endocrinology Division A/S | Dry growth hormone composition transiently linked to a polymer carrier |
CA2796826A1 (en) | 2010-05-10 | 2011-11-17 | Gilead Sciences, Inc. | Bifunctional quinoline derivatives |
US8367829B2 (en) | 2010-05-10 | 2013-02-05 | Gilead Sciences, Inc. | Bi-functional pyrazolopyridine compounds |
CA2801936C (en) | 2010-06-21 | 2021-06-01 | Mannkind Corporation | Dry powder drug delivery system and methods |
EP2672986B1 (en) | 2011-02-09 | 2020-03-18 | GlaxoSmithKline LLC | Lyophilized formulations |
EP2694402B1 (en) | 2011-04-01 | 2017-03-22 | MannKind Corporation | Blister package for pharmaceutical cartridges |
WO2012174472A1 (en) | 2011-06-17 | 2012-12-20 | Mannkind Corporation | High capacity diketopiperazine microparticles |
AR086745A1 (es) | 2011-06-27 | 2014-01-22 | Parion Sciences Inc | 3,5-diamino-6-cloro-n-(n-(4-(4-(2-(hexil(2,3,4,5,6-pentahidroxihexil)amino)etoxi)fenil)butil)carbamimidoil)pirazina-2-carboxamida |
EP2776053A1 (en) | 2011-10-24 | 2014-09-17 | MannKind Corporation | Methods and compositions for treating pain |
US9643996B2 (en) | 2011-11-04 | 2017-05-09 | Battelle Memorial Institute | Processes for producing protein microparticles |
US9034347B2 (en) * | 2011-12-19 | 2015-05-19 | Arphios Corporation | Drug delivery system and method for the treatment of neuro-degenerative disease |
WO2013096883A2 (en) * | 2011-12-23 | 2013-06-27 | The Regents Of The University Of California | Spray dry method for encapsulation of biological moieties and chemicals in polymers cross-linked by multivalent ions for controlled release applications |
CN102552166A (zh) * | 2012-01-09 | 2012-07-11 | 北京化工大学 | 一种溶菌酶/聚(α-氰基丙烯酸异丁酯)载药微球的制备方法 |
US20130280332A1 (en) * | 2012-02-17 | 2013-10-24 | Nexbio, Inc. | Methods, Compounds and Compositions for Treatment of Influenza and Parainfluenza Patients |
EP2855435B1 (en) | 2012-05-29 | 2018-04-11 | Parion Sciences, Inc. | Dendrimer like amino amides possessing sodium channel blocker activity for the treatment of dry eye and other mucosal diseases |
US20140154308A1 (en) * | 2012-06-28 | 2014-06-05 | Ansun Biopharma, Inc. | Microparticle Formulations for Delivery to the Upper and Central Respiratory Tract and Methods of Manufacture |
WO2014005103A2 (en) * | 2012-06-28 | 2014-01-03 | Ansun Biopharma, Inc. | Microparticle formulations for delivery to the lower and central respiratory tract and methods of manufacture |
US20140017318A1 (en) * | 2012-07-10 | 2014-01-16 | Kevin O'Connell | Method to produce a medicinal product comprising a biologically active protein and the resulting product |
AU2013289957B2 (en) | 2012-07-12 | 2017-02-23 | Mannkind Corporation | Dry powder drug delivery systems and methods |
CN102757726B (zh) * | 2012-08-07 | 2014-04-09 | 湖南罗比特化学材料有限公司 | 一种基于天然多羟基糖类制备的水性uv涂料及其方法 |
US9314519B2 (en) | 2012-08-21 | 2016-04-19 | Intervet Inc. | Liquid stable virus vaccines |
US10828276B2 (en) | 2012-11-28 | 2020-11-10 | Aphios Corporation | Combination therapeutics and methods for the treatment of neurodegenerative and other diseases |
ES2674665T3 (es) | 2012-12-17 | 2018-07-03 | Parion Sciences, Inc. | Compuestos de 3,5-diamino-6-cloro-N-(N-(4-fenilbutilo)carbamimidoilo)-pirazina-2-carboxamida |
MX2015007797A (es) | 2012-12-17 | 2015-10-05 | Parion Sciences Inc | Compuestos de 3,5-diamino-6-cloro-n-(n-(4-fenilbutil) carbamimidoil) pirazin-2-carboxamida. |
CA2895512C (en) | 2012-12-17 | 2021-10-19 | Parion Sciences, Inc. | Chloro-pyrazine carboxamide derivatives useful for the treatment of diseases favoured by insufficient mucosal hydration |
US9757395B2 (en) | 2012-12-20 | 2017-09-12 | Otitopic Inc. | Dry powder inhaler and methods of use |
US9757529B2 (en) | 2012-12-20 | 2017-09-12 | Otitopic Inc. | Dry powder inhaler and methods of use |
CN103109800B (zh) * | 2013-02-26 | 2015-04-08 | 广州市锐博生物科技有限公司 | 壳聚糖纳米粒、防治小菜蛾的生物农药制剂及其制备方法 |
CN103109798B (zh) * | 2013-02-26 | 2015-04-08 | 广州市锐博生物科技有限公司 | 壳聚糖纳米粒、防治红火蚁的生物农药制剂及其制备方法 |
CN103109799B (zh) * | 2013-02-26 | 2015-04-08 | 广州市锐博生物科技有限公司 | 壳聚糖纳米粒、防治斜纹夜蛾的生物农药制剂及其制备方法 |
EP2968189A4 (en) * | 2013-03-15 | 2016-11-16 | Ansun Biopharma Inc | METHOD FOR PRODUCING INJECTABLE PROTEIN MICROPARTICLE SUSPENSIONS |
US9393298B2 (en) | 2013-03-15 | 2016-07-19 | Intervet Inc. | Liquid stable bovine virus vaccines |
US9480739B2 (en) | 2013-03-15 | 2016-11-01 | Intervet Inc. | Bovine virus vaccines that are liquid stable |
JP2016518388A (ja) | 2013-04-30 | 2016-06-23 | オティトピック インク. | 乾燥粉末配合および使用方法 |
WO2014207769A1 (en) | 2013-06-27 | 2014-12-31 | Mylan Laboratories Ltd | Process for the preparation of nepafenac |
MX2020009878A (es) | 2013-07-18 | 2022-07-27 | Mannkind Corp | Composiciones farmaceuticas en polvo seco estables al calor y metodos. |
AR097762A1 (es) | 2013-09-27 | 2016-04-13 | Intervet Int Bv | Formulaciones secas de vacunas que son estables a temperatura ambiente |
AR099470A1 (es) | 2014-02-17 | 2016-07-27 | Intervet Int Bv | Vacunas de virus de aves de corral líquidas |
TWI670085B (zh) | 2014-02-19 | 2019-09-01 | 荷蘭商英特威國際公司 | 液體穩定之豬病毒疫苗 |
US10307464B2 (en) | 2014-03-28 | 2019-06-04 | Mannkind Corporation | Use of ultrarapid acting insulin |
WO2016044656A1 (en) | 2014-09-17 | 2016-03-24 | Ansun Biopharma, Inc. | Treatment of infection by human enterovirus d68 |
DE102014114403A1 (de) * | 2014-10-02 | 2016-04-07 | Gerresheimer Regensburg Gmbh | Stopfen zum Aufsetzen auf ein Anschlusselement einer medizinischen Spritze |
EP3220892B1 (en) | 2014-11-21 | 2021-10-13 | Ascendis Pharma Endocrinology Division A/S | Long-acting growth hormone dosage forms |
CN104523659A (zh) * | 2015-01-19 | 2015-04-22 | 陈长潭 | 一种胸腺五肽吸入粉雾剂及其制备方法 |
CN106924715A (zh) * | 2015-12-31 | 2017-07-07 | 深圳翰宇药业股份有限公司 | 特利加压素脂质体及其制备方法 |
CN105963257B (zh) * | 2016-04-26 | 2021-01-22 | 广州帝奇医药技术有限公司 | 一种缓释微粒的制备方法 |
CN106075403A (zh) * | 2016-06-12 | 2016-11-09 | 暨南大学 | 一种胰岛素口服硒纳米制剂及其制备方法 |
KR102581747B1 (ko) | 2016-07-01 | 2023-09-22 | 더 보드 오브 트러스티스 오브 더 리랜드 스탠포드 쥬니어 유니버시티 | 표적 세포 표면 편집을 위한 접합체 |
KR20180007322A (ko) * | 2016-07-11 | 2018-01-22 | 주식회사 삼양바이오팜 | 고분자 마이크로스피어의 연속 제조방법 및 이를 위한 장치 |
AU2017300392B2 (en) * | 2016-07-18 | 2022-06-16 | Tissuegen, Inc. | Methods and compositions for maintaining the conformation and structural integrity of biomolecules |
CN109803672A (zh) | 2016-09-13 | 2019-05-24 | 阿勒根公司 | 稳定的非蛋白质梭菌毒素组合物 |
DE102017104277A1 (de) * | 2017-03-01 | 2018-09-06 | Lts Lohmann Therapie-Systeme Ag | Transmukosales Verabreichungssystem für Idebenon |
US10786456B2 (en) | 2017-09-22 | 2020-09-29 | Otitopic Inc. | Inhaled aspirin and magnesium to treat inflammation |
JP7493449B2 (ja) | 2017-09-22 | 2024-05-31 | ヴェクチュラ インコーポレイテッド | ステアリン酸マグネシウムを含む乾燥粉末組成物 |
MX2020007024A (es) | 2018-01-03 | 2020-10-28 | Palleon Pharmaceuticals Inc | Sialidasas humanas recombinantes, proteinas de fusion de sialidasa y metodos para usar las mismas. |
CN108853492A (zh) * | 2018-07-25 | 2018-11-23 | 中国医学科学院生物医学工程研究所 | 治疗自身性免疫疾病的疫苗佐剂及其应用 |
CN109678964B (zh) * | 2018-12-21 | 2022-02-25 | 陕西师范大学 | 一种利托菌素磁珠、制备方法及其应用 |
CN110664758B (zh) * | 2019-10-15 | 2021-11-30 | 无锡市人民医院 | Pai-cpt还原响应型双药递送纳米粒子的制备方法 |
CN110923628B (zh) * | 2019-11-06 | 2021-11-26 | 南京理工大学 | 一种新型表面团簇分子的制备方法 |
WO2021151005A1 (en) * | 2020-01-22 | 2021-07-29 | Ansun Biopharma, Inc. | Inhaled das181 to treat cancer in the lung |
US20230346793A1 (en) * | 2020-05-28 | 2023-11-02 | Mickey Hu | Compositions and Methods for Treating SARS-CoV-2 |
CN112472664B (zh) * | 2020-11-17 | 2022-02-25 | 中国矿业大学 | 一种基因靶向治疗的纳米马达-水凝胶体系制备方法 |
CA3237027A1 (en) * | 2021-11-02 | 2023-05-11 | Ansun Biopharma Inc. | Das181 variant compositions |
CN113893384B (zh) * | 2021-11-08 | 2022-06-21 | 山东省科学院生物研究所 | 一种交联壳聚糖微球及其在创面止血修复材料中的应用 |
CN114377200B (zh) * | 2022-01-12 | 2023-03-24 | 北京阅色科技发展中心(有限合伙) | 面部注射填充用可生物降解亲水高分子微球及制备方法 |
CN114652734A (zh) * | 2022-03-31 | 2022-06-24 | 李红梦 | 一种祛痘的药物组合物及其制备方法 |
CN115770232A (zh) * | 2022-10-28 | 2023-03-10 | 苏州大学 | 一种地佐辛缓释微球及其制备方法 |
Family Cites Families (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3439089A (en) * | 1968-03-27 | 1969-04-15 | Merck & Co Inc | Medicated hard candy |
US5052558A (en) * | 1987-12-23 | 1991-10-01 | Entravision, Inc. | Packaged pharmaceutical product |
US5033252A (en) * | 1987-12-23 | 1991-07-23 | Entravision, Inc. | Method of packaging and sterilizing a pharmaceutical product |
US5145702A (en) * | 1988-09-19 | 1992-09-08 | Opta Food Ingredients, Inc. | Hydrophobic protein microparticles and preparation thereof |
US6063910A (en) * | 1991-11-14 | 2000-05-16 | The Trustees Of Princeton University | Preparation of protein microparticles by supercritical fluid precipitation |
US5323907A (en) * | 1992-06-23 | 1994-06-28 | Multi-Comp, Inc. | Child resistant package assembly for dispensing pharmaceutical medications |
US5981719A (en) * | 1993-03-09 | 1999-11-09 | Epic Therapeutics, Inc. | Macromolecular microparticles and methods of production and use |
US6090925A (en) * | 1993-03-09 | 2000-07-18 | Epic Therapeutics, Inc. | Macromolecular microparticles and methods of production and use |
US5578709A (en) | 1993-03-09 | 1996-11-26 | Middlesex Sciences, Inc. | Macromolecular microparticles and methods of production |
US6051256A (en) * | 1994-03-07 | 2000-04-18 | Inhale Therapeutic Systems | Dispersible macromolecule compositions and methods for their preparation and use |
WO1998006279A1 (en) * | 1996-08-09 | 1998-02-19 | Gibson Suzanne M | Heat-stable protein microparticles and no-shear process for producing same |
GB9909066D0 (en) * | 1999-04-20 | 1999-06-16 | Oxford Glycosciences Uk Ltd | Therapies |
GB9910975D0 (en) | 1999-05-13 | 1999-07-14 | Univ Strathclyde | Rapid dehydration of proteins |
US6458387B1 (en) * | 1999-10-18 | 2002-10-01 | Epic Therapeutics, Inc. | Sustained release microspheres |
US6331317B1 (en) | 1999-11-12 | 2001-12-18 | Alkermes Controlled Therapeutics Ii Inc. | Apparatus and method for preparing microparticles |
US7807174B2 (en) * | 2002-11-22 | 2010-10-05 | Nexbio, Inc. | Class of therapeutic protein based molecules |
KR20050085130A (ko) * | 2002-11-22 | 2005-08-29 | 유 망 | 광범위 스펙트럼의 항-바이러스 치료제 및 예방제 |
KR101137785B1 (ko) * | 2003-07-18 | 2012-04-25 | 백스터 인터내셔널 인코포레이티드 | 제어된 상 분리에 의해 제조된 작은 구형 입자의 제조방법, 이용 방법 및 조성물 |
JP2007512006A (ja) * | 2003-11-10 | 2007-05-17 | ザ ユーエービー リサーチ ファウンデーション | 細菌輸送およびcns侵襲を低減させるための組成物およびこの組成物を使用する方法 |
CA2555921A1 (en) * | 2004-02-13 | 2005-09-15 | Nod Pharmaceuticals, Inc. | Therapeutic calcium phosphate particles and methods of making and using same |
US8728525B2 (en) * | 2004-05-12 | 2014-05-20 | Baxter International Inc. | Protein microspheres retaining pharmacokinetic and pharmacodynamic properties |
EP1753404A1 (en) | 2004-05-12 | 2007-02-21 | Baxter International Inc. | Microspheres comprising protein and showing injectability at high concentrations of said agent |
KR101787939B1 (ko) | 2006-01-24 | 2017-10-18 | 안선 바이오파르마, 아이엔씨. | 고분자 미소 구체들의 조제를 위한 기술 |
WO2009015286A2 (en) | 2007-07-24 | 2009-01-29 | Nexbio, Inc. | Technology for the preparation of microparticles |
-
2007
- 2007-01-24 KR KR1020167034961A patent/KR101787939B1/ko active IP Right Grant
- 2007-01-24 BR BRPI0706947A patent/BRPI0706947B8/pt active IP Right Grant
- 2007-01-24 RU RU2008134282/15A patent/RU2464973C2/ru active
- 2007-01-24 KR KR1020087020607A patent/KR101501780B1/ko active IP Right Grant
- 2007-01-24 CA CA2639925A patent/CA2639925C/en active Active
- 2007-01-24 KR KR1020207012978A patent/KR102180849B1/ko active IP Right Grant
- 2007-01-24 EP EP07709816A patent/EP1981483A1/en active Pending
- 2007-01-24 JP JP2008552388A patent/JP5457680B2/ja active Active
- 2007-01-24 AU AU2007233349A patent/AU2007233349A1/en not_active Abandoned
- 2007-01-24 US US11/657,812 patent/US20070190163A1/en not_active Abandoned
- 2007-01-24 WO PCT/US2007/001914 patent/WO2007114881A1/en active Application Filing
- 2007-01-24 CN CN201510100563.2A patent/CN104758253A/zh active Pending
- 2007-01-24 KR KR20147032523A patent/KR20150001844A/ko active Application Filing
- 2007-01-24 CA CA2932997A patent/CA2932997C/en active Active
- 2007-01-24 KR KR1020177021297A patent/KR102109867B1/ko active IP Right Grant
- 2007-01-24 CN CNA200780010254XA patent/CN101404980A/zh active Pending
-
2008
- 2008-07-23 IL IL193001A patent/IL193001A/en active IP Right Grant
- 2008-08-19 ZA ZA200807133A patent/ZA200807133B/xx unknown
-
2009
- 2009-10-05 HK HK15111665.4A patent/HK1210720A1/xx unknown
- 2009-12-08 US US12/633,773 patent/US20100166874A1/en not_active Abandoned
-
2011
- 2011-11-04 US US13/289,644 patent/US8623419B2/en active Active
-
2012
- 2012-07-11 RU RU2012131203A patent/RU2628807C2/ru active
- 2012-12-12 JP JP2012271571A patent/JP6063239B2/ja active Active
-
2014
- 2014-01-06 US US14/148,543 patent/US20140134150A1/en not_active Abandoned
-
2015
- 2015-04-21 US US14/692,461 patent/US20150290134A1/en not_active Abandoned
- 2015-07-30 IL IL240268A patent/IL240268A0/en active IP Right Grant
-
2017
- 2017-09-25 US US15/715,041 patent/US10583086B2/en active Active
-
2020
- 2020-03-09 US US16/813,622 patent/US20200197310A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL240268A0 (en) | Technology for the preparation of macromolecular microspheres | |
TWI372079B (en) | Microspheres | |
ZA200900142B (en) | Microspheres | |
ZA200807758B (en) | Microspheres | |
GB0711952D0 (en) | Microspheres | |
GB0604899D0 (en) | Derivatives of 18-glycyrrhetinic acid | |
IL196228A0 (en) | 4-hydroxythiobenzamide derivatives of drugs | |
GB0705854D0 (en) | Methods of construction | |
IL196594A0 (en) | Derivatives of 4-trimethylammonium-3-aminobutyrate and 4-trimethylphosphonium-3-aminobutyrate as cpt-inhibitors | |
ZA200900927B (en) | Glyoxalation of vinylmide polymer | |
ZA200900230B (en) | 4-hydroxythiobenzamide derivatives of drugs | |
HUE037655T2 (hu) | Egy észteráz elõállítása | |
IL196320A0 (en) | Derivatives and analogs of n-ethylquinolones and n-ethylazaquinolones | |
GB0623897D0 (en) | Pharmaceutical composition of memantine | |
HUP0600117A2 (en) | Structure of road | |
EP1997114A4 (en) | COMPOSITIONS OF MATERIAL: SYSTEM II | |
EP2100345A4 (en) | ANTENNA OF PARALLEL ANNULAR TYPE | |
TWM301105U (en) | Improved structure of socket | |
GB201114396D0 (en) | Location of basesation | |
GB0622341D0 (en) | Novel compounds and methods for their preparation | |
TWM298442U (en) | Improved structure of sprinkle-nozzle for fire-extinguisher | |
TWM311768U (en) | Improved structure of A-ladder | |
GB0612370D0 (en) | Uses of (S)-clenbuterol | |
GB0614601D0 (en) | Microspheres | |
IL198836A0 (en) | Processes for preparation of 9-haloacetamidomidominocyclines |